Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?
- PMID: 28561773
- PMCID: PMC5485992
- DOI: 10.3390/ijms18061168
Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?
Abstract
Alzheimer's disease (AD) is a multifaceted disease that is hard to treat by single-modal treatment. AD starts with amyloid peptides, mitochondrial dysfunction, and oxidative stress and later is accompanied with chronic endoplasmic reticulum (ER) stress and autophagy dysfunction, resulting in more complicated pathogenesis. Currently, few treatments can modify the complicated pathogenic progress of AD. Compared to the treatment with exogenous antioxidants, the activation of global antioxidant defense system via Nrf2 looks more promising in attenuating oxidative stress in AD brains. Accompanying the activation of the Nrf2-mediated antioxidant defense system that reduce the AD-causative factor, oxidative stress, it is also necessary to activate the neurotrophic signaling pathway that replaces damaged organelles and molecules with new ones. Thus, the dual actions to activate both the Nrf2 antioxidant system and neurotrophic signaling pathway are expected to provide a better strategy to modify AD pathogenesis. Here, we review the current understanding of AD pathogenesis and neuronal defense systems and discuss a possible way to co-activate the Nrf2 antioxidant system and neurotrophic signaling pathway with the hope of helping to find a better strategy to slow AD.
Keywords: Alzheimer’s disease; Nrf2; amyloid peptide; mitochondrial damage; natural products; neurotrophic signaling pathway; oxidative stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5485992/bin/ijms-18-01168-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5485992/bin/ijms-18-01168-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5485992/bin/ijms-18-01168-g003.gif)
Similar articles
-
Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.Curr Aging Sci. 2014;7(2):77-90. doi: 10.2174/1874609807666140804115633. Curr Aging Sci. 2014. PMID: 25101711 Review.
-
Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system.J Biol Chem. 2018 Nov 23;293(47):18242-18269. doi: 10.1074/jbc.RA117.001245. Epub 2018 Oct 3. J Biol Chem. 2018. PMID: 30282635 Free PMC article.
-
Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease.Biochim Biophys Acta. 2015 Jul;1852(7):1428-41. doi: 10.1016/j.bbadis.2015.03.015. Epub 2015 Apr 6. Biochim Biophys Acta. 2015. PMID: 25857617
-
Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease.Mech Ageing Dev. 2016 Jan;153:41-7. doi: 10.1016/j.mad.2016.01.002. Epub 2016 Jan 23. Mech Ageing Dev. 2016. PMID: 26811881 Review.
-
Activation of Nrf2/ARE pathway alleviates the cognitive deficits in PS1V97L-Tg mouse model of Alzheimer's disease through modulation of oxidative stress.J Neurosci Res. 2019 Apr;97(4):492-505. doi: 10.1002/jnr.24357. Epub 2018 Nov 21. J Neurosci Res. 2019. PMID: 30461032
Cited by
-
Trametinib activates endogenous neurogenesis and recovers neuropathology in a model of Alzheimer's disease.Exp Mol Med. 2023 Oct;55(10):2177-2189. doi: 10.1038/s12276-023-01073-2. Epub 2023 Oct 2. Exp Mol Med. 2023. PMID: 37779138 Free PMC article.
-
Signaling Pathways Involved in the Neuroprotective Effect of Osthole: Evidence and Mechanisms.Mol Neurobiol. 2024 Feb;61(2):1100-1118. doi: 10.1007/s12035-023-03580-9. Epub 2023 Sep 8. Mol Neurobiol. 2024. PMID: 37682453 Review.
-
Sargachromenol Isolated from Sargassum horneri Attenuates Glutamate-Induced Neuronal Cell Death and Oxidative Stress through Inhibition of MAPK/NF-κB and Activation of Nrf2/HO-1 Signaling Pathway.Mar Drugs. 2022 Nov 12;20(11):710. doi: 10.3390/md20110710. Mar Drugs. 2022. PMID: 36421988 Free PMC article.
-
Pentoxifylline Enhances Antioxidative Capability and Promotes Mitochondrial Biogenesis in D-Galactose-Induced Aging Mice by Increasing Nrf2 and PGC-1α through the cAMP-CREB Pathway.Oxid Med Cell Longev. 2021 Jun 22;2021:6695613. doi: 10.1155/2021/6695613. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34257818 Free PMC article.
-
Vitamin K2 Modulates Organelle Damage and Tauopathy Induced by Streptozotocin and Menadione in SH-SY5Y Cells.Antioxidants (Basel). 2021 Jun 20;10(6):983. doi: 10.3390/antiox10060983. Antioxidants (Basel). 2021. PMID: 34202933 Free PMC article.
References
-
- De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., Klein W.L. Aβ oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 2007;282:11590–11601. doi: 10.1074/jbc.M607483200. - DOI - PubMed
-
- Ma Q.L., Yang F., Rosario E.R., Ubeda O.J., Beech W., Gant D.J., Chen P.P., Hudspeth B., Chen C., Zhao Y., et al. β-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin. J. Neurosci. 2009;29:9078–9089. doi: 10.1523/JNEUROSCI.1071-09.2009. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical